Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour pen has arrived in a plain box, tracked through DPD, and it's sitting in the fridge. Now what? Making the most of Mounjaro for weight loss isn't just about the injection itself — it's about what you build around it. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for weight management in the UK, and the clinical evidence is strong, but the results people see vary considerably depending on how they use the time the medicine creates. These are prescription-only medicines; a GPhC-registered prescriber assesses whether treatment is appropriate for you before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people start Mounjaro at 2.5mg, a tolerability dose whose job is adjusting your system rather than producing rapid weight loss. Expect the appetite changes to be subtle at first. The real shift in hunger usually comes at 5mg and beyond. Knowing this stops early weeks from feeling like the medicine isn't working.
Nausea is the most commonly reported side effect at the start, and it tends to concentrate in the 24–48 hours after an injection. Eating smaller portions, choosing lower-fat foods during that window, and staying well hydrated can all reduce its intensity. Fizzy drinks, greasy meals and large portions are the things patients most often wish they'd avoided in week one. The tirzepatide overview has more on what the evidence says about typical tolerability across the SURMOUNT trials.
Injection technique is worth getting right early. Rotate between your abdomen, thigh and upper arm on a weekly basis, returning to the same spot repeatedly can cause skin changes. Always refer to the Patient Information Leaflet for the exact room-temperature storage window; the figure in the leaflet is the one to follow, not secondary sources. A colder pen straight from the fridge can sting slightly; letting it reach room temperature for a few minutes before injecting helps.
One thing our prescribers hear regularly: people wondering whether the pen worked because they felt so little from the injection itself. The mechanism is hormonal, not immediate, it works over days, not minutes. Trust the process, and log how your hunger and portions change across the week rather than hour by hour.
Tirzepatide reduces appetite significantly for most people, and that's precisely its value, but it also creates a specific risk. When you eat substantially less without thinking about what you're eating, it's easy to under-consume protein. Muscle loss during rapid weight loss is a genuine concern, and protein helps limit it. A general working target for people on GLP-1 treatment is around 1.2–1.6g of protein per kilogram of body weight per day, though your prescriber or a dietitian can set a more personalised figure. The NHS tirzepatide medicines page outlines what to expect alongside treatment.
Fibre matters too. Constipation is a common side effect, and a diet low in vegetables, legumes and wholegrains can make it worse. Hydration alongside fibre is the practical fix most people find helpful, aim for water consistently through the day rather than large amounts at once, which can aggravate nausea.
Eating slowly is not just a wellness cliche on this treatment. Because gastric emptying is slowed, fullness signals arrive later than usual. If you eat at your normal pace you may overshoot what your stomach can comfortably hold, leading to nausea or reflux. Putting down the fork between bites, smaller plates, and meals without screens are practical adjustments that genuinely help. Alcohol is worth reducing, it adds empty calories, affects judgement around food, and some people find their tolerance changes on treatment.
For men specifically, protein targets and the muscle-preservation point deserve extra attention; Mounjaro for men explores the considerations in more detail.
Mounjaro's licence specifies use alongside reduced-calorie diet and increased physical activity. The clinical trials that demonstrated its effectiveness were conducted with lifestyle support in place. Movement doesn't have to mean gym sessions, the evidence for walking, resistance bands, swimming and cycling is solid, and the most important variable is consistency over intensity.
Resistance training (bodyweight exercises, weights, resistance bands) is particularly worth considering during weight loss because it helps preserve muscle mass as the number on the scale drops. This isn't about building bulk; it's about making sure the weight you lose comes predominantly from fat rather than lean tissue. Even two sessions a week makes a measurable difference in the research literature. The Mounjaro treatment page covers the licensed indication in full.
Fatigue is a side effect some people experience, particularly in the early weeks. This is the wrong time to push through an ambitious new training programme. Walking is genuinely sufficient to start, 20–30 minutes most days covers the lifestyle component and is sustainable. Build intensity once the side-effect profile has settled. If you want a fuller picture of what the weight-loss evidence looks like across the SURMOUNT programme, the NICE appraisal of tirzepatide, NICE TA1026, is the primary UK clinical reference.
Sleep is the piece most Mounjaro weight-loss tips overlook entirely. Sleep deprivation elevates ghrelin (a hunger hormone) and reduces leptin (a satiety hormone), it directly undermines the appetite regulation the medicine is working to support. Seven to nine hours matters.
Some things are for you to manage day to day: food choices, portion sizes, exercise, hydration. Other things are for your prescriber. Dose timing, dose increases, what to do after a missed injection, these sit firmly in the clinical column. The Patient Information Leaflet covers missed doses; your prescriber covers everything the leaflet doesn't resolve. At nume, every repeat order is clinically re-reviewed before dispatch; the aftercare team is available seven days a week if something feels wrong between orders.
Side effects worth flagging urgently rather than waiting for your next review: severe, persistent stomach pain that radiates to the back (a potential sign of pancreatitis), symptoms of an allergic reaction, or significant dehydration from vomiting or diarrhoea. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is the place to report any adverse reaction.
People sometimes ask whether they can switch to the oral route if injections aren't working for them. That's a clinical conversation, not a self-directed switch. Similarly, if you've heard of how the prescription process works but aren't sure you meet the criteria, the free consultation at nume is the right starting point, it's where a prescriber, not an algorithm, assesses the full picture. If you're ready to check whether treatment is right for you, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.